Shufang Cai
-
- Muscle Physiology and Disorders 8
- Ubiquitin and proteasome pathways 4
- RNA Research and Splicing 4
- RNA modifications and cancer 3
- Metabolomics and Mass Spectrometry Studies 2
-
- Tissue Engineering and Regenerative Medicine 3
-
- Adipose Tissue and Metabolism 3
-
- Advanced Glycation End Products research 3
- Journals
- Journal of Agricultural and Food Chemistry (1 paper)The FASEB Journal (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaCanadaUnited Kingdom
In The Last Decade
Shufang Cai
28 papers receiving 503 citations
Peers
Comparison fields: 5 of 90
- Neurology 53
- Developmental Neuroscience 18
- Aging 7
- Molecular Biology 268
- Cancer Research 58
Countries citing papers authored by Shufang Cai
This map shows the geographic impact of Shufang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufang Cai more than expected).
Fields of papers citing papers by Shufang Cai
This network shows the impact of papers produced by Shufang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufang Cai. The network helps show where Shufang Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shufang Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 28 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 32 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 77 | |
| 12 | 2021 | 20 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 27 | |
| 15 | 2021 | 24 | |
| 16 | 2021 | 34 | |
| 17 | 2021 | 14 | |
| 18 | 2019 | 5 | |
| 19 | 2019 | 19 | |
| 20 | 2018 | 18 |
About Shufang Cai
Shufang Cai is a scholar working on Clinical Biochemistry, Genetics and Molecular Biology, having authored 30 papers that have together received 509 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (8 papers), Ubiquitin and proteasome pathways (4 papers), RNA Research and Splicing (4 papers), Tissue Engineering and Regenerative Medicine (3 papers), Adipose Tissue and Metabolism (3 papers), RNA modifications and cancer (3 papers), Advanced Glycation End Products research (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Neurology (53 citations), Developmental Neuroscience (18 citations) and Aging (7 citations). Shufang Cai has collaborated with scholars based in China, Canada and United Kingdom. Frequent co-authors include Delin Mo, Yaosheng Chen, Qi Zhu, Yanqing Wu, Renqiang Yuan, Jian Xiao, Xumeng Zhang, Jingyu Xu, Yuan Yuan and Jiaxin Zhao. Their work appears in journals such as Journal of Agricultural and Food Chemistry, The FASEB Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.